We are committed to making a meaningful impact on patients' lives.

Our mission is to develop transformative medicines for orphan diseases of the kidney.

  • Life-threatening Genetic Disease
  • 4th Leading Cause of Kidney Failure
  • No Approved Drug Treatments in the US
  • Learn More
Please join Palladio Biosciences as we present new data about lixivaptan during the American Society of Nephrology's Kidney Week in New Orleans, October 31-November 5, 2017.